Skip to main navigation Skip to search Skip to main content

Human biomonitoring in risk assessment: analysis of the current practice and 1st examples on the use of HBM in risk assessments of HBM4EU priority chemicals

  • M. Heinälä
  • , J. Bessems
  • , J. Buekers
  • , C. Cornelis
  • , T. Vermeire
  • , M. Woutersen
  • , J. van Engelen
  • , T. Borges
  • , C. Rousselle
  • , E. Ougier
  • , H. Louro
  • , P. Alvito
  • , C. Martins
  • , R. Assuncao
  • , M. J. Silva
  • , L. Krul
  • , A. Pronk
  • , B. Schaddelee-Scholten
  • , R. Stierum
  • , M. C. Gonzalez
  • M. de Alba, G. Diaz, S. Viegas, T. Humar-Juric, K. Abraham, Anne Marie Vinggaard
  • Finnish Institute of Occupational Health
  • Flemish Institute for Technological Research
  • National Institute of Public Health and the Environment
  • Directorate-General of Health
  • Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail
  • National Institute of Health Dr. Ricardo Jorge
  • Netherlands Organisation for Applied Scientific Research
  • Carlos III National Institute of Health
  • Lisbon School of Health Technology
  • Federal Institute for Risk Assessment

Research output: Book/ReportReportCommissioned

730 Downloads (Orbit)
Original languageEnglish
Number of pages123
Publication statusPublished - 2017

Bibliographical note

Report for H2020 EU Joint Program HBM4EU

Cite this